CoChat

Sex and gender differences in cancer pathogenesis and pharmacology

Open access
Bernardez, Beatriz, Higuera, Oliver, Martinez-Callejo, Virginia, Cardeña-Gutiérrez, Ana, Marcos Rodríguez, José Antonio, Santaballa Bertrán, Ana, Majem, Margarita, Moreno-Martínez, Maria-Estela · 2025 · Clinical and Translational Oncology

The DOI matches its Crossref record; 92 of the 94 references it cites were found in a registry or an index.

Abstract

Sex and gender may influence the epidemiology, pathogenesis, and prognosis of cancer. This narrative review describes sex and gender differences in the epidemiology and pathogenesis of cancer, and how such differences may impact the pharmacodynamics and pharmacokinetics of cancer treatment. For most types of cancer unrelated to reproductive function, incidence is higher in males than in females, except for gallbladder and thyroid cancers, which are much more common in women. Cancer mortality is higher in men than women; women account for a larger proportion of survivors. These differences may be related to biological differences in pathogenesis or differences in behaviors relating to cancer risk or detection. The pharmacokinetics and pharmacodynamics of cancer therapies also differ between sexes due to differences in body composition, physiology, and receptor expression. Overall, sex and gender are essential variables to be considered in research and clinical practice, influencing diagnosis, subtyping (biomarkers), prognostication, treatment, and dosage.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s12094-025-03894-1

Cites

92 of 92 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Proportion of males and females among new diagnoses of selected non-reproductive cancers (left) and among those living with selected non-reproductive cancers over 5 years (right) according to GLOBOCAN 2022 data [9, 10]. CNS central nervous system
Fig. 1 Proportion of males and females among new diagnoses of selected non-reproductive cancers (left) and among those living with selected non-reproductive cancers over 5 years (right) according to GLOBOCAN 2022 data [9, 10]. CNS central nervous systemCC BY · PubMed Central
Fig. 2 Differential effects of sex hormones on immune cells [40]. Ig immunoglobulin, IL interleukin. Figure adapted from Irelli A, et al. Biomedicines 2020;8(7):232 (https://doi.org/10.3390/biomedicines8070232), under the terms and conditions of the Creative Commons Attribution 4.0 International (CC BY 4.0) license (http://creativecommons.org/licenses/by/4.0/). Adaptations from the original figure include a simpler presentation of key concepts and a shorter figure legend
Fig. 2 Differential effects of sex hormones on immune cells [40]. Ig immunoglobulin, IL interleukin. Figure adapted from Irelli A, et al. Biomedicines 2020;8(7):232 (https://doi.org/10.3390/biomedicines8070232), under the terms and conditions of the Creative Commons Attribution 4.0 International (CC BY 4.0) license (http://creativecommons.org/licenses/by/4.0/). Adaptations from the original figure include a simpler presentation of key concepts and a shorter figure legendCC BY · PubMed Central
Fig. 3 Metabolic differences between male and female cancer cells [27]. *Prior to menopause. CRC colorectal cancer, GLUT1 uniporter glucose transporter 1, MCT monocarboxylic acid transporter, NADPH nicotinamide adenine dinucleotide phosphate, NSCLC non-small cell lung cancer, PP pentose phosphate, TCA tricarboxylic acid
Fig. 3 Metabolic differences between male and female cancer cells [27]. *Prior to menopause. CRC colorectal cancer, GLUT1 uniporter glucose transporter 1, MCT monocarboxylic acid transporter, NADPH nicotinamide adenine dinucleotide phosphate, NSCLC non-small cell lung cancer, PP pentose phosphate, TCA tricarboxylic acidCC BY · PubMed Central
Fig. 4 Sex-related anatomical and physiological differences that affect drug pharmacokinetics and generally result in higher systemic exposure in females than in males [2, 75]. *Affected by body mass index. AUC area under the concentration–time curve, Cmax maximal plasma concentration, CYP450 cytochrome P450, GI gastrointestinal, tmax time to maximal plasma concentration
Fig. 4 Sex-related anatomical and physiological differences that affect drug pharmacokinetics and generally result in higher systemic exposure in females than in males [2, 75]. *Affected by body mass index. AUC area under the concentration–time curve, Cmax maximal plasma concentration, CYP450 cytochrome P450, GI gastrointestinal, tmax time to maximal plasma concentrationCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 92 references

Cited by

See all 33

Metadata

Authors
Bernardez, B., Higuera, O., Martinez-Callejo, V., Cardeña-Gutiérrez, A., Marcos Rodríguez, J. A., Santaballa Bertrán, A., Majem, M., & Moreno-Martínez, M.-E.
Affiliations
  • Hospital Universitario La Paz (ES)
  • Hospital Universitario Nuestra Señora de Candelaria (ES)
  • Hospital de Sant Pau (ES)
Corresponding author
Cardeña-Gutiérrez, Ana
Venue
Clinical and Translational Oncology
Published
2025-04-01
Volume
27
Issue
10
Pages
3837-3848
ISSN
  • 1699-048X (ISSN-L)
  • 1699-3055
OpenAlex
W4409086376
Cited by
27
References
94
Citations by year
2026: 21 · 2025: 6
FWCI
5.15
Type
journal article
Language
en
Open access
Licence
Locations
  • Clinical & Translational Oncology (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • PubMed Central (publishedVersion, cc-by)
  • Dipòsit Digital de Documents de la UAB (Universitat Autònoma de Barcelona) (submittedVersion, cc-by)
  • Hispana (submittedVersion, cc-by)
  • Deposito de Investigacion Universidad de Sevilla (University of Seville) (submittedVersion, cc-by)
Funders
  • Organon
  • Sociedad Española de Oncología Médica
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Sex and Gender in Healthcare
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
  • Health Sciences › Medicine › Oncology › Cancer Risks and Factors
Keywords
sex differences, gender differences, cancer epidemiology, carcinogenesis, pharmacodynamics, cancer mortality, cancer incidence, body composition, receptor expression, tumor markers, cancer prognosis, dosage
MeSH terms
Antineoplastic Agents, Female, Humans, Male, Neoplasms, Prognosis, Sex Characteristics, Sex Factors, Incidence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Sex and gender differences in cancer pathogenesis and pharmacology. https://app.cochat.ai/papers/10.1007/s12094-025-03894-1
The paper
Bernardez, B., Higuera, O., Martinez-Callejo, V., Cardeña-Gutiérrez, A., Marcos Rodríguez, J. A., Santaballa Bertrán, A., Majem, M., & Moreno-Martínez, M.-E. (2025). Sex and gender differences in cancer pathogenesis and pharmacology. Clinical and Translational Oncology. https://doi.org/10.1007/s12094-025-03894-1

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.